isospaglumic acid has been researched along with Nerve Pain in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bubeníková-Valešová, V; Franěk, M; Rokyta, R; Šťastný, F; Vaculín, S; Yamamotová, A | 1 |
| Bzdega, T; Janczura, KJ; Lavin, KM; Madore, JC; Neale, JH; Olszewski, RT; Profaci, CP; Zuo, D | 1 |
| Carpenter, KJ; Dickenson, AH; Flatters, SL; Matthews, EA; Sen, S; Slusher, BS; Wozniak, KM | 1 |
| Belozertseva, I; Bespalov, A; Danysz, W; Eilbacher, B; Greco, S; Jirgensons, A; Kashkin, V; Malyshkin, A; Nagel, J; Shekunova, E | 1 |
1 review(s) available for isospaglumic acid and Nerve Pain
| Article | Year |
|---|---|
Advances in understanding the peptide neurotransmitter NAAG and appearance of a new member of the NAAG neuropeptide family.
Topics: Animals; Astrocytes; Brain Injuries; Dipeptides; Glutamate Carboxypeptidase II; Humans; Hyperalgesia; Neuralgia; Neuropeptides; Neurotransmitter Agents; Peripheral Nervous System Diseases; Protease Inhibitors; Schizophrenia; Substance-Related Disorders | 2011 |
3 other study(ies) available for isospaglumic acid and Nerve Pain
| Article | Year |
|---|---|
Pain perception in neurodevelopmental animal models of schizophrenia.
Topics: Age Factors; Animals; Animals, Newborn; Dipeptides; Disease Models, Animal; Female; Hot Temperature; Humans; Injections, Intraventricular; Male; Neuralgia; Nociceptors; Pain Measurement; Pain Threshold; Physical Stimulation; Proto-Oncogene Proteins c-fos; Quinolinic Acid; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Schizophrenia | 2010 |
Effects of GCP-II inhibition on responses of dorsal horn neurones after inflammation and neuropathy: an electrophysiological study in the rat.
Topics: Animals; Carrageenan; Dipeptides; Disease Models, Animal; Electric Stimulation; Glutamate Carboxypeptidase II; Ligation; Male; Nerve Fibers, Myelinated; Nerve Fibers, Unmyelinated; Neuralgia; Neuritis; Nociceptors; Organophosphorus Compounds; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; Spinal Nerves | 2003 |
Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration.
Topics: Analgesics, Non-Narcotic; Animals; Biotransformation; Blood-Brain Barrier; Brain Chemistry; Chronic Disease; Dipeptides; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Extracellular Fluid; Glutamate Carboxypeptidase II; Injections, Intraperitoneal; Ligation; Male; Microdialysis; Models, Animal; Neuralgia; Neuroprotective Agents; Organophosphorus Compounds; Pain Threshold; Pyridazines; Quinolines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptors, Metabotropic Glutamate; Sciatic Nerve | 2006 |